SutureTech earned FDA 510(k) clearance for its RapidFix device for soft tissue to bone fixation in orthopedic surgeries.
RapidFix is a suture-based internal fixation device and developed through eight years of surgeon collaboration, according to a Sept. 16 news release.
Following clearance, the company plans a limited market release of RapidFix in the fourth quarter.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
